Medexus Pharmaceuticals (MDP) Competitors

Medexus Pharmaceuticals (TSE:MDP) and Leaf Mobile (TSE:LEAF) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, community ranking, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations.

Does the MarketBeat Community favor MDP or LEAF?

Leaf Mobile received 160 more outperform votes than Medexus Pharmaceuticals when rated by MarketBeat users. However, 71.43% of users gave Medexus Pharmaceuticals an outperform vote while only 65.89% of users gave Leaf Mobile an outperform vote.

Company	Underperform	Outperform
Medexus Pharmaceuticals	Outperform Votes 10 71.43%	Underperform Votes 4 28.57%
Leaf Mobile	Outperform Votes 170 65.89%	Underperform Votes 88 34.11%

Is MDP or LEAF more profitable?

Medexus Pharmaceuticals has a net margin of 3.25% compared to Leaf Mobile's net margin of 0.00%. Medexus Pharmaceuticals' return on equity of 11.07% beat Leaf Mobile's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medexus Pharmaceuticals	3.25%	11.07%	4.89%
Leaf Mobile	N/A	N/A	N/A

Which has stronger valuation & earnings, MDP or LEAF?

Leaf Mobile has lower revenue, but higher earnings than Medexus Pharmaceuticals. Leaf Mobile is trading at a lower price-to-earnings ratio than Medexus Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medexus Pharmaceuticals	C$100.25M	0.57	C$3.26M	C$0.21	12.19
Leaf Mobile	C$83.74M	0.00	C$3.37M	C$0.04	N/A

Do institutionals & insiders have more ownership in MDP or LEAF?

8.3% of Medexus Pharmaceuticals shares are owned by institutional investors. 9.1% of Medexus Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the media favor MDP or LEAF?

In the previous week, Medexus Pharmaceuticals' average media sentiment score of 0.00 equaled Leaf Mobile'saverage media sentiment score.

Company	Overall Sentiment
Medexus Pharmaceuticals	Neutral
Leaf Mobile	Neutral

Do analysts recommend MDP or LEAF?

Medexus Pharmaceuticals currently has a consensus target price of C$5.49, suggesting a potential upside of 115.20%. Given Medexus Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Medexus Pharmaceuticals is more favorable than Leaf Mobile.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medexus Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	4 Strong Buy rating(s)	3.29
Leaf Mobile	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Medexus Pharmaceuticals beats Leaf Mobile on 12 of the 15 factors compared between the two stocks.